CopyFind
Tiptengio 10mg/5mg Tablet
medicine 📍 IN

Tiptengio 10mg/5mg Tablet

750,00 ₹

Аналоги Tiptengio 10mg/5mg Tablet

Знайдіть доступніші аналоги та дженерики для Tiptengio 10mg/5mg Tablet.

Інгредієнти

Активний інгредієнт: Empagliflozin; Linagliptin


Опис товару

About Tiptengio

Tiptengio is a medication containing the active ingredient empagliflozin, classified as Sodium-Glucose Cotransporter 2 Inhibitor. Empagliflozin, sold under the brand name Jardiance, among others, is an antidiabetic medication used to improve glucose control in people with type 2 diabetes and/or for patients with established heart failure with reduced ejection fraction (HFrEF).

Key Benefits & Uses

  • Used for: 1 INDICATIONS AND USAGE SYNJARDY SYNJARDY is a combination of empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor and metformin.
  • Use only as directed on the product label or by a healthcare professional.
  • Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

empagliflozin, the active ingredient in Tiptengio, belongs to the Sodium-Glucose Cotransporter 2 Inhibitor class. 1 INDICATIONS AND USAGE SYNJARDY SYNJARDY is a combination of empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor and metformin hydrochloride (HCl) immediate-release, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Tiptengio. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Tiptengio for extended periods without medical advice.

Знайти в аптеках

Порівняйте місцеві ціни та відстань для Tiptengio 10mg/5mg Tablet.

Оцінки відвідувачів

Допоможіть іншим — оцініть корисність цієї сторінки.

Оцінок ще немає — будьте першим.